Wortham Laboratories, Inc.
Wortham Laboratories is an emerging leader in hemostatic wound healing and coagulation products, with a core flagship product called SeraSeal, the world's first primary hemostatic agent. The company aims to improve surgical efficiency, reduce costs, and enhance patient outcomes through innovative medical devices. With international headquarters in the United States and a global distributor network, Wortham Laboratories is dedicated to developing products that save lives, increase surgical efficiency, and assist first responders.
Industries
Nr. of Employees
small (1-50)
Wortham Laboratories, Inc.
1234 Medical Drive, Chattanooga, TN, USA
Products
Primary topical hemostatic agent
A topical hemostatic formulation designed to achieve rapid hemostasis when applied to bleeding wounds in surgical, emergency, and pre-hospital contexts.
Primary topical hemostatic agent
A topical hemostatic formulation designed to achieve rapid hemostasis when applied to bleeding wounds in surgical, emergency, and pre-hospital contexts.
Services
Provision of instructional videos, animations, and guidance materials for clinical application of topical hemostatic products.
Management of distribution partners and provision of technical service to support product implementation in multiple countries.
Provision of instructional videos, animations, and guidance materials for clinical application of topical hemostatic products.
Management of distribution partners and provision of technical service to support product implementation in multiple countries.
Expertise Areas
- Hemostatic agent development
- Wound care and hemorrhage control
- Clinical training and education
- Clinical product manufacturing
Key Technologies
- Topical hemostatic biomaterials
- Wound sealing and hemostasis formulations
- Clinical training videos and animations
- Comparative clinical benchmarking methods
News & Updates
Animation example of SeraSeal application on transected arterial bleed.
Overview of SeraSeal, its purpose, marketplace, and performance as the world's first primary hemostatic agent.
Discussion on how SeraSeal helps reduce healthcare costs by controlling bleeding efficiently.
Over One Million Successful SeraSeal Cases
SeraSeal has been successfully used in over one million procedures worldwide.
Animation example of SeraSeal application on transected arterial bleed.
Overview of SeraSeal, its purpose, marketplace, and performance as the world's first primary hemostatic agent.
Discussion on how SeraSeal helps reduce healthcare costs by controlling bleeding efficiently.
Over One Million Successful SeraSeal Cases
SeraSeal has been successfully used in over one million procedures worldwide.